NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-029-2006-1-ES-01 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF ES EP 06837414.9 Issued
NICHD E-047-2006-0-JP-06 Sensing Phage-triggered Ion Cascade (SEPTIC) JP National Stage 2007-543553 Abandoned
NIDDK E-149-2006-1-US-01 Three Genes That Either Enhance Growth In HEK-293 Cells Or Modify Adhesion In HeLa Cells US 60/931,439 Abandoned
NCI E-264-2004-0-US-03 Combining Phage Lambda Genetics And Protein Display For The Identification Of Multi Complex Protein Structures. US National Stage 11/719,925 Abandoned
NHLBI E-237-2003-0-US-03 Fisptrain: A High Signal Magnetic Resonance Imaging (MRI) Sequence With Steady-state Free Precession And Intrinsic Fat Suppression US CON 11/751,479 7880466 Expired PDF
NCI E-057-1994-2-US-11 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 11/751,233 7612044 Expired PDF
NIAID E-171-2007-0-US-01 Adaptive Mutations That Increase The Infectivity Of Hepatitis C Virus JFJ1 In Cell Culture US 60/931,259 Abandoned
NIAID E-220-2007-0-US-01 Gram Positive Three-Component Antimicrobial Peptide-Sensing System US 60/930,709 Abandoned
NIAID E-174-2007-0-US-01 Pseudocoelomic Fluid From Ascaris Serum Protects From Allergic Diseases US 60/924,537 Abandoned
NEI E-094-2003-0-US-03 Steroid Formulation And Methods of Treatment Using Same US National Stage 11/791,125 Abandoned
NIDDK E-223-2006-0-EP-05 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS EP National Stage 07777162.4 Abandoned
NIDDK E-223-2006-0-JP-06 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS JP National Stage 2009-511097 Abandoned
NIDDK E-223-2006-0-PCT-02 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS PCT PCT PCT/US07/011951 Expired
NIDDK E-223-2006-0-AU-03 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS AU National Stage 2007254165 Abandoned
NIDDK E-223-2006-0-CA-04 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS CA National Stage 2652061 Abandoned
NINDS E-014-2006-2-JP-12 Assays For Diagnosing and Evaluating Treatment Options for Fabry Disease JP DIV 2012-285265 Issued
NINDS E-014-2006-2-HK-09 Assays For Diagnosing and Evaluating Treatment Options for Fabry Disease HK EP 09107461.6 Issued
NINDS E-014-2006-2-HU-29 Treatment Options For Fabry Disease HU EP 12168451.8 Issued
NINDS E-014-2006-2-IS-31 Treatment Options For Fabry Disease IS EP 12168451.8 Issued
NINDS E-014-2006-2-IT-32 Treatment Options For Fabry Disease IT EP 12168451.8 Issued
NINDS E-014-2006-2-IE-30 Treatment Options For Fabry Disease IE EP 12168451.8 Issued
NINDS E-014-2006-2-GR-28 Treatment Options For Fabry Disease GR EP 12168451.8 Issued
NINDS E-014-2006-2-MT-38 Treatment Options For Fabry Disease MT EP 12168451.8 Issued
NINDS E-014-2006-2-LI-33 Treatment Options For Fabry Disease LI EP 12168451.8 Issued
NINDS E-014-2006-2-LT-34 Treatment Options For Fabry Disease LT EP 12168451.8 Issued
NINDS E-014-2006-2-LU-35 Treatment Options For Fabry Disease LU EP 12168451.8 Issued
NINDS E-014-2006-2-LV-36 Treatment Options For Fabry Disease LV EP 12168451.8 Issued
NINDS E-014-2006-2-AT-15 Treatment Options For Fabry Disease AT EP 12168451.8 Issued
NINDS E-014-2006-2-BE-16 Treatment Options For Fabry Disease BE EP 12168451.8 Issued
NINDS E-014-2006-2-CZ-20 Treatment Options For Fabry Disease CZ EP 12168451.8 Issued
NINDS E-014-2006-2-CY-19 Treatment Options For Fabry Disease CY EP 12168451.8 Issued
NINDS E-014-2006-2-BG-17 Treatment Options For Fabry Disease BG EP 12168451.8 Issued
NINDS E-014-2006-2-GB-27 Treatment Options For Fabry Disease GB EP 12168451.8 Issued
NINDS E-014-2006-2-SE-43 Treatment Options For Fabry Disease SE EP 12168451.8 Issued
NINDS E-014-2006-2-ES-24 Treatment Options For Fabry Disease ES EP 12168451.8 Issued
NINDS E-014-2006-2-TR-46 Treatment Options For Fabry Disease TR EP 12168451.8 Issued
NINDS E-014-2006-2-CH-18 Treatment Options For Fabry Disease CH EP 12168451.8 Issued
NINDS E-014-2006-2-EE-23 Treatment Options For Fabry Disease EE EP 12168451.8 Issued
NINDS E-014-2006-2-FR-26 Treatment Options For Fabry Disease FR EP 12168451.8 Issued
NINDS E-014-2006-2-DE-21 Treatment Options For Fabry Disease DE EP 12168451.8 Issued
NINDS E-014-2006-2-DK-22 Treatment Options For Fabry Disease DK EP 12168451.8 Issued
NINDS E-014-2006-2-FI-25 Treatment Options For Fabry Disease FI EP 12168451.8 Issued
NINDS E-014-2006-2-PT-41 Treatment Options For Fabry Disease PT EP 12168451.8 Issued
NINDS E-014-2006-2-NL-39 Treatment Options For Fabry Disease NL EP 12168451.8 Issued
NINDS E-014-2006-2-MC-37 Treatment Options For Fabry Disease MC EP 12168451.8 Issued
NINDS E-014-2006-2-RO-42 Treatment Options For Fabry Disease RO EP 12168451.8 Issued
NINDS E-014-2006-2-SK-45 Treatment Options For Fabry Disease SK EP 12168451.8 Issued
NINDS E-014-2006-2-SI-44 Treatment Options For Fabry Disease SI EP 12168451.8 Issued
NINDS E-014-2006-2-PL-40 Treatment Options For Fabry Disease PL EP 12168451.8 Issued
NINDS E-014-2006-2-EP-10 Treatment Options For Fabry Disease EP DIV 12168451.8 Issued